🇺🇸 FDA
Patent

US 8097636

Heterocyclic derivatives as modulators of ion channels

granted A61PA61P1/02A61P1/04

Quick answer

US patent 8097636 (Heterocyclic derivatives as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18